ARCHIVES

Sorafenib Targets AML Driven By Mutant FLT3 Gene

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Health Reform Bill Contains Unpleasant Surprises For Drug Manufacturers

November 5, 1993

President’s Budget Versus NCI’s Bypass: A Comparison

February 21, 1992

CPRU Program Gets Basic Concept Approval

October 2, 1987

Senators Urge Grassroots Support For Health Research Fund Legislation

May 16, 1997

ORI Whistle-Blower Proposal Too Rigid, Biologists Say.

February 2, 2001

President’s Budget Request for FDA Omits Funding for Critical Path.

February 8, 2008